CD2-induced apoptosis in activated human peripheral T cells: A fas-independent pathway that requires early protein tyrosine phosphorylation

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3184-3190

  Mollereau, Bertrand ^a   Deckert, Marcel ^c   Déas, Olivier ^a   Rieux Laucat, Frederic ^b   Hirsch, François ^a   Bernard, Alain ^c   Fischer, Alain ^b   Lynch, David H ^d   Charpentier, Bernard ^a   Le Deist, Françoise ^b   Senik, Anna ^a,e  

^a Equipe d'Immunol Cell Transplant   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d AMGEN INC   (United States)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN;

APOPTOSIS; ARTICLE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNITY; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD2; ANTIGENS, CD3; ANTIGENS, CD95; APOPTOSIS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MUTATION; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0029919954     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kerr, J. F. R., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide range implications in tissue kinetics. Br. J. Cancer 26: 239.
2. Raff, M. C. 1992. Social control on cell survival and cell death. Nature 356:397.
3. Wyllie, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555.
4. low thymocytes in vivo. Science 250: 1720.
5. Russel, J. H., C. L. White, D. Y. Loh, and P. Meleedy-Rey. 1991. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sci. USA 88:2151.
6. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
7. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Möller, W. Falk, K.-M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
8. Wesselborg, S., U. Prüfer, M. Wild, B. Schraven, S. C. Meuer, and D. Kabelitz. 1993. Triggering via the alternative CD2 pathway induces apoptosis in activated human lymphocytes. 23:2707.
9. + T cells is induced by some combinations of anti-CD2 mAb. J. Immunol. 151:3547.
10. Rouleau, M., B. Mollereau, A. Bernard, D. Metivier, M. A. Rosenthal-Allieri, B. Charpentier, and A. Senik. 1994. Mitogenic CD2 monoclonal antibody pairs predispose peripheral T cells to undergo apoptosis upon interaction with a third CD2 monoclonal antibody. J. Immunol. 152:4861.
11. Hueber, A.-O., G. Raposo, M. Pierres, and H.-T. He. 1994. Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism. J. Exp. Med. 179:785.
12. Dustin, M. L., M. E. Sanders, S. Shaw, and T. A. Springer. 1987. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J. Exp. Med. 165:677.
13. Deckert, M., J. Kubar, D. Zoccola, G. Bernard-Pomier, P. Angelisova, V. Horejsi, and A. Bernard. 1992. CD59 molecule: a second ligand for CD2 in T cell adhesion. Eur. J. Immunol. 22:2943.
14. Hann, W. C., E. Menu, A. L. M. Bothwell, P. J. Sims, and B. E. Bierer. 1992. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256:1805.
15. Arulanandam, A. R. N., P. Moingeon, M. F. Concino, M. A. Recny, K. Kato, H. Yagita, S. Koyasu, and E. L. Reinherz. 1993. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J. Exp. Med. 177:1439.
16. Bierer, B. E., B. P. Sleckman, S. E. Ratnofsky, and S. J. Burakoff. 1989. The biological roles of CD2, CD4, and CD8 in T-cell activation. Annu. Rev. Immunol. 7:579.
17. Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. L. Hodgdon, J. F. Potentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role for the 50 kD T11 sheep erythrocyte receptor protein. Cell 36:897.
18. Ley, S. C., A. A. Davies, B. Druker, and M. J. Crumpton. 1991. The T cell receptor/CD3 complex and CD2 stimulate the tyrosine phosphorylation of indistinguishable patterns of polypeptides in the human T leukemic cell line Jurkat. Eur. J. Immunol. 21:2203.
19. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
20. Dhein, J., H. Walczak, C. Bäumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373:438.
21. Brunner, T., R. J. Mogli, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
22. Ju, S.-T., D. J. Panka, H. Cul, R. Ettinger, M. El-Khatib, D. H. Sher, B. Z. Stanger, and A. Marak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after activation. Nature 373:444.
23. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas gene of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756.
24. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
25. Russel, J. H., B. Rush, C. Weaver, and R. Wang. 1993. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90:4409.
26. Takahashi, T., M. Tamaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969.
27. Rieux-Laucat, F., F. Le Deist, C. Hivroz, A. G. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
28. Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 268:10932.
29. Tartaglia, L. A., T. M. Ayres, G. H. W. Wong, and D. V. Goeddel. 1993. A novel domain within the 55 kD TNF receptor signals cell death. Cell 74:845.
30. Alderson, M. R., T. W. Tough, S. Braddy, T. Davis-Smith, E. Roux, K. Schooley, R. E. Miller, and D. H. Lynch. 1994. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6:1799.
31. Eischen, C. M., C. J. Dick, and P. J. Leibson. 1994. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153:1947.
32. Bell, G. M., J. B. Bolen, and J. B. Imboden. 1992. Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol. Cell. Biol. 12:5548.
33. fyn. Eur. J. Immunol. 23:2196.
34. lck is increased in human T cells activated via CD2. Eur. J. Immunol. 21:1967.
35. June, C. H., M. C. Fletcher, J. A. Ledbetter, G. L. Schieven, J. N. Siegel, A. F. Phillips, and L. E. Samelson. 1990. Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 87:7722.
36. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
37. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
38. Sarin, A., M. Conan-Cibotti, and P. A. Henckart. 1995. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 155:3716.
39. Herold, K. C., D. W. Lancki, R. L. Moldwin, and F. W. Fitch. 1986. Immunosuppressive effects of cyclosporin A on cloned T cells. J. Immunol. 136:1315.
40. + cytotoxic T lymphocyte-mediated lysis. J. Immunol. 150:4303.
41. Gillette-Ferguson, I., and C. Sidman. 1994. A specific intracellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur. J. Immunol. 24:1181.
42. Mogli, R. J., L. Radvany, R. Gonzalez-quintial, R. Miller, G. Mills, A. N. Theofilopoulos, and D. R. Green. 1995. Fas (CD95) participates in peripheral T cell deletion and associates apoptosis in vivo. Int. Immunol. 7:1451.
43. Howard, F. D., P. Moingeon, U. Moebius, D. J. McConkey, B. Yandava, T. E. Gennert, and E. L. Reinhertz. 1992. The CD3ζ cytoplasmic domain mediates CD2-induced activation. J. Exp. Med. 176:139.
44. Chan, A. C., M. Iwashima, C. W. Turck, and A. Weiss. 1993. ZAP-70: a 70 kD protein tyrosine kinase that associates with the TCRζ chain. Cell 71:649.
45. Schulze-Osthoff, K., P. H. Krammer, and W. Dröge. 1994. Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13:4587.
46. Su, X., T. Zhou, Z. Wang, P. Yang, R. S. Jope, and J. D. Mountz. 1995. Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2:353.
47. Sato, T., S. We, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. 268:411.
48. Cifone, M. G., R. DeMaria, P. Roncaioli, M. R. Rippo, M. Azuma, L. L. Lanier, A. Santoni, and R. Testi. 1993. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 177:547.
49. Gill, B., H. Nishikata, H. Chan, T. L. Delovitch, and A. Ochi. 1994. Fas antigen and sphingomyelin-ceramide turnover-mediated signaling: role in life and death of T lymphocytes. Immunol. Rev. 142:113.
50. Gulbins, E., R. Bissonnette, A. Mahboubi, S. Martin, W. Nishioka, T. Brunner, G. Baier, G. Baier-Bitterlich, C. Byrd, F. Lang, R. Kolesnick, A. Altman, and D. Green. 1995. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2:341.
51. Alderson, M. R., R. J. Armitage, E. Marakovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. Lynch. 1993. Fas transduce activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
52. Qin, L., K. D. Chavin, J. Lin, H. Yagita, and J. S. Bromberg. 1994. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J. Exp. Med. 179:341.
53. + T cells. J. Exp. Med. 180:2125.
54. Boussiotis, V. A., G. J. Freeman, J. D. Griffin, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1994. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180:1665.
55. Bernard, A., C. Gelin, B. Raynal, D. Pham, G. Gosse, and L. Boumsell. 1982. Phenomenon of T cell rosetting with sheep erythrocytes analyzed with monoclonal antibodies: "modulation" of partially hidden epitopes determining the conditions of interaction between T cells and erythrocytes. J. Exp. Med. 155:1317.